Group 1: Financial Performance - The revenue structure for the third quarter remains stable, with fuel ethanol accounting for approximately 52% of total revenue, starch and starch sugar products slightly exceeding 30%, and other products contributing less than 20% [2] - The main source of gross profit in the first three quarters comes from alcohol products, benefiting from increased sales prices of fuel ethanol and effective control of raw material costs [2] - The overall debt ratio of the company is about 40%, indicating a relatively good asset condition, with significant reductions in short-term debt from approximately 65-70 billion CNY at the end of last year to around 26 billion CNY in Q3 [3] Group 2: Market Trends and Projections - Oil prices are expected to remain high due to various factors including supply-demand relationships, economic recovery, and geopolitical influences [3] - The market demand for polylactic acid (PLA) is projected to exceed 1 million tons by 2025, with some forecasts suggesting it could surpass 2 million tons [4] - The company anticipates that the price of PHA (polyhydroxyalkanoates) will remain stable in the long term due to its high-end application fields [5] Group 3: Raw Material Management - Corn prices remain high, with corn accounting for over 70% of the raw material cost for fuel ethanol production, making price fluctuations significant [3] - The company has achieved breakthroughs in production technology, allowing for flexible use of various raw materials, including corn, aged rice, and cassava, enabling dynamic adjustments based on price conditions [3] Group 4: Product Development and Innovation - The company is actively advancing its sugar substitute projects, particularly in erythritol and allulose, with a strong patent portfolio and industry chain foundation [5] - The company is constructing a 1,000 tons/year PHA facility, which is expected to enhance its position in the biodegradable materials industry and improve profitability [5] - The company plans to expand its product line in functional syrups, with over 30 varieties already developed for various applications [5]

Financial Performance - The company's revenue for Q3 2022 was ¥4,287,062,608.64, a decrease of 29.26% compared to ¥6,059,928,874.39 in the same period last year[7]. - Net profit attributable to shareholders was ¥179,738,947.16, down 23.49% from ¥234,913,119.48 year-on-year[7]. - Basic earnings per share decreased to ¥0.0970, down 23.68% from ¥0.1271 in the same period last year[7]. - Total operating revenue for the current period is ¥14,896,319,948.47, a decrease of 17.5% compared to ¥18,086,356,343.33 in the previous period[26]. - Net profit for the current period is ¥1,274,260,552.53, slightly up from ¥1,253,096,605.47 in the previous period[26]. - The net profit for the current period is approximately ¥987.26 million, an increase from ¥940.08 million in the previous period, representing a growth of about 5%[28]. - The total comprehensive income for the current period is approximately ¥1,024.57 million, compared to ¥906.83 million in the previous period, indicating an increase of around 13%[28]. - The basic earnings per share for the current period is ¥0.5195, up from ¥0.5055 in the previous period, reflecting a growth of about 2.0%[28]. Cash Flow and Assets - The net cash flow from operating activities was ¥1,640,249,107.89, a significant decline of 68.74% compared to ¥5,246,962,076.13 in the previous year[12]. - Cash flow from operating activities for the current period is approximately ¥1,640.25 million, a decrease from ¥5,246.96 million in the previous period[32]. - Cash and cash equivalents at the end of the period amount to approximately ¥1,386.76 million, compared to ¥1,283.58 million at the end of the previous period, showing an increase of about 8%[32]. - The company's cash and cash equivalents were reported at 1,388,936,499.07 CNY, up from 1,115,957,159.62 CNY at the start of the year, indicating a growth of approximately 24.5%[19]. - The total assets at the end of the reporting period were ¥18,062,119,861.99, reflecting a slight increase of 0.12% compared to the previous year[7]. - Total assets increased to ¥18,078,897,719.28 from ¥18,058,126,434.00, reflecting a growth of 0.11%[25]. - The company's fixed assets increased to 8,429,500,327.18 CNY from 7,781,661,600.53 CNY, indicating a growth of about 8.3%[19]. Liabilities and Equity - Total liabilities decreased to ¥5,734,181,449.10 from ¥6,303,484,786.33, a reduction of 9%[25]. - The total equity attributable to shareholders was ¥11,397,350,949.32, an increase of 4.98% compared to the previous year[7]. - The total equity attributable to shareholders of the parent company rose to ¥11,960,731,504.18, an increase of 5% from ¥11,393,240,662.95[25]. Operating Costs and Expenses - The company’s gross profit margin decreased, with operating costs at ¥13,077,858,593.39, down 17.90% from ¥15,929,579,111.08[12]. - Total operating costs for the current period are ¥13,781,857,723.36, down 18.4% from ¥16,844,208,399.69 in the previous period[26]. - The company reported a decrease in R&D expenses to ¥97,035,272.22, down 25.96% from ¥131,058,912.06 year-on-year[12]. - Research and development expenses decreased to ¥97,035,272.22, a reduction of 26% from ¥131,058,912.06 in the previous period[26]. - The company reported a tax expense of approximately ¥296.11 million, down from ¥318.64 million in the previous period, reflecting a decrease of about 7%[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 129,731, with COFCO Bio-chemical Investment Co., Ltd. holding 47.35% of shares, amounting to 883,233,262 shares[15]. - The total number of preferred shareholders and their holdings were not applicable for this reporting period[18]. - The report indicates that there are no known related party relationships among the top ten shareholders, ensuring independent governance[15]. Government Support and Other Income - The company received government subsidies amounting to ¥446,839,537.42 year-to-date, which is a significant contribution to other income[11]. - The company’s financial expenses decreased significantly by 106.46% to -¥8,053,157.05 due to reduced loan interest and increased exchange gains[12]. Market Strategy - The company is focused on expanding its market presence and developing new products and technologies, although specific details were not disclosed in the report[17]. - The company has not reported any significant mergers or acquisitions during this period[17].

证券代码：000930 证券简称：中粮科技 公告编号：2022-059 中粮生物科技股份有限公司 关于参加安徽辖区上市公司 2022 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 为进一步加强与投资者的互动交流，中粮生物科技股份有限公司（以下简称公司） 将参加由安徽证监局指导、安徽上市公司协会与深圳市全景网络有限公司联合举办的 "2022 年安徽辖区上市公司投资者集体接待日活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP,参与本 次互动交流，活动时间为 2022 年 9 月 7 日（周三） 16:00-17:30。届时公司总会计 师胡昌平先生，董事会秘书潘喜春先生及相关人员将在信息披露允许的范围内就投资 者普遍关注的问题与投资者进行线上沟通与交流。欢迎广大投资者踊跃参与。 特此公告。 中粮生物科技股份有限公司 董 事 会 2022 年 9 月 2 日 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥10,609,257,339.83, a decrease of 11.78% compared to the same period last year[27]. - The net profit attributable to shareholders was ¥785,688,457.89, an increase of 12.21% year-on-year[27]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥631,434,064.53, a decrease of 3.64% compared to the previous year[27]. - The net cash flow from operating activities was -¥60,220,288.92, a decline of 102.91% compared to the same period last year[27]. - Basic earnings per share were ¥0.4229, an increase of 11.79% year-on-year[27]. - Total assets at the end of the reporting period were ¥19,283,554,204.73, an increase of 6.79% from the end of the previous year[27]. - Net assets attributable to shareholders at the end of the reporting period were ¥11,754,641,149.87, an increase of 3.17% compared to the end of the previous year[27]. - The company reported a net increase in cash and cash equivalents of ¥47,385,719.99, which is a decrease of 89.66% from ¥458,250,467.56 in the same period last year[46]. - Domestic revenue accounted for 87.09% of total operating revenue, amounting to ¥9,239,667,190.42, down 18.71% year-on-year[49]. - International revenue increased by 107.32% to ¥1,369,590,149.41, representing 12.91% of total operating revenue[49]. Strategic Initiatives - The company is actively pursuing a "three transformations" strategy in the fuel ethanol sector, focusing on raw material diversification, product flexibility, and market-oriented operations[37]. - The company has successfully completed the trial run of its PHA project, establishing a foundation for producing PHA and PLA blend materials[38]. - The company has enhanced its procurement strategy by innovatively utilizing frozen corn and diversifying raw material sources, which has improved cost efficiency[42]. - The company has made significant advancements in product innovation, including the development of new formulations for various food products and improvements in fermentation processes[42]. - The company is focusing on expanding its market presence and enhancing customer relationships through tailored solutions and differentiated products[39]. Environmental Compliance - The company reported a total COD emission of 153.99 tons, which exceeds the regulatory limit of 50 tons by 207.98%[87]. - The ammonia nitrogen (NH3-N) emission from the company reached 14.67 tons, surpassing the standard limit of 5 tons by 193.4%[87]. - The sulfur dioxide (SO2) emissions were recorded at 739.68 tons, significantly above the allowable limit of 200 tons by 269.84%[87]. - The nitrogen oxides (NOx) emissions totaled 739.68 tons, exceeding the limit of 200 tons by 269.84%[87]. - The company has multiple subsidiaries, all of which reported various levels of emissions, indicating a widespread environmental compliance issue across operations[87]. - The company has implemented direct discharge methods for wastewater and exhaust gases in several facilities, raising concerns about environmental impact[87]. - Continuous monitoring and compliance with environmental regulations are prioritized, with all facilities reporting stable and compliant emissions[91]. - The company has implemented various advanced treatment processes, including anaerobic and aerobic treatments, across multiple subsidiaries, with specific focus on reducing emissions[93]. Shareholder and Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company has implemented a restricted stock incentive plan, granting up to 31,830,700 shares, which accounts for 1.723% of the total issued capital[80]. - The company completed the repurchase and cancellation of shares, reducing the total number of shares from 1,865,717,988 to 1,865,273,596[83]. - The company has confirmed that all guarantees have been fulfilled as of the reporting date[173]. - The total number of common shareholders at the end of the reporting period is 131,653[198]. - The company has a good integrity status, with no unfulfilled court judgments or significant overdue debts[150]. Risk Management - The company faced significant risks from fluctuations in grain and oil prices, exacerbated by geopolitical factors and unexpected U.S. interest rate hikes[71]. - The company plans to enhance raw material inventory control and diversify procurement to mitigate grain price volatility risks[71]. - The company aims to increase production flexibility and strengthen strategic partnerships with major clients to address oil price volatility risks[73]. Future Outlook - The company expects 2023 overall performance to grow by XX%[108]. - The company is focusing on enhancing the added value of agricultural products through biotechnology innovations[120]. - The company is committed to maintaining stable support for poverty alleviation and rural revitalization initiatives, ensuring the sustainability of its efforts[121].

Financial Performance - The company reported a total revenue of 1,865,273,596 RMB for the year, with a cash dividend of 2.45 RMB per 10 shares distributed to shareholders[6]. - The company's operating revenue for 2021 was ¥23,468,553,115.67, representing a 17.88% increase compared to ¥19,909,350,658.56 in 2020[28]. - The net profit attributable to shareholders in 2021 was ¥1,133,198,037.30, a significant increase of 91.06% from ¥593,116,803.94 in 2020[28]. - The net profit after deducting non-recurring gains and losses reached ¥1,054,340,097.55 in 2021, up 102.28% from ¥521,231,909.82 in 2020[28]. - The net cash flow from operating activities improved to ¥4,841,590,965.35 in 2021, a 266.33% increase from -¥2,910,855,638.13 in 2020[28]. - The basic earnings per share for 2021 was ¥0.6127, reflecting a 90.93% increase compared to ¥0.3209 in 2020[28]. - The total operating revenue for 2021 reached ¥23,468,553,115.67, representing a year-on-year increase of 17.88% compared to ¥19,909,350,658.56 in 2020[72]. - The revenue from agricultural product processing and sales accounted for 98.60% of total revenue, amounting to ¥23,141,074,192.25, with a year-on-year growth of 20.17%[72]. - The company achieved a historic breakthrough with revenue exceeding 20 billion RMB and net profit reaching over 1 billion RMB, marking a year-on-year increase in performance despite global economic challenges[62]. Shareholder and Capital Structure - The company’s total share capital increased to 1,865,763,788 shares following the completion of a restricted stock grant, with the controlling shareholder's stake slightly decreasing to 47.34%[24]. - COFCO Bio-chemical Investment Co., Ltd. became the controlling shareholder with a 47.80% stake after the completion of a stock issuance for asset acquisition[24]. - The company’s actual controller, COFCO Group, holds a total of 1,035,233,262 shares, representing 55.49% of the total shares[24]. - The company implemented a cash dividend policy, distributing CNY 2.45 per 10 shares, totaling CNY 456,992,031.02 for the year, which represents 100% of the total profit distribution[196]. Business Operations and Strategy - The company’s main business shifted to include fuel ethanol, edible alcohol, starch, starch sugar, citric acid, and monosodium glutamate since 2018[24]. - The company is experiencing increased operational pressure due to rising corn prices and energy costs, impacting the corn starch industry[40]. - The corn deep processing industry in China is facing challenges due to policy adjustments, significant fluctuations in raw material prices, and overcapacity, while industry consolidation is expected to accelerate[42]. - The company maintains a leading position in the fuel ethanol industry, achieving significant profit growth through diversified raw material utilization and continuous optimization of fermentation processes[51]. - The company is committed to innovation and continuous improvement in production processes to meet the growing demand for specialized products driven by consumer trends[42]. - The company’s strategy includes a diversified raw material approach and flexible production to ensure sustainable operations in the fuel ethanol sector[45]. - The company is positioned to benefit from the increasing market demand for functional high-end food additives and biodegradable materials due to health and environmental concerns[42]. - The company is actively developing biodegradable materials in response to national policies on plastic pollution, with projects underway for a 30,000-ton lactide production facility and a kiloton-level PHA production unit[51]. Research and Development - The company has developed an international leading cellulose ethanol technology solution, obtaining 62 patent authorizations and completing a 50,000-ton demonstration facility process package[46]. - The company is advancing key fermentation technology for fuel ethanol, aiming to reduce overall production costs and enhance process levels[92]. - The company is developing multi-grain fermentation technology to diversify raw material applications, which is expected to lower raw material costs for alcohol products[92]. - The company is increasing R&D investment to drive sustainable development, focusing on functional sugar products and cellulose ethanol technology[137]. - Research and development expenses increased by 4.93% to CNY 119,277,453.53 in 2021 compared to CNY 113,672,793.15 in 2020[89]. - R&D investment increased by 4.21% from ¥114,386,332.05 in 2020 to ¥119,196,565.97 in 2021, while the proportion of R&D investment to operating revenue decreased from 0.57% to 0.51%[93]. Environmental and Sustainability Initiatives - The company’s production facilities achieved zero wastewater discharge in fuel ethanol production, setting a precedent in the industry for environmental sustainability[58]. - The company is committed to sustainable development, integrating green practices into its operations and achieving 100% compliance in pollution source monitoring[55]. - The company is implementing "dual carbon" goals, focusing on carbon reduction measures and energy management systems to lead industry green transformation[137]. Market and Sales Performance - The company reported a quarterly operating revenue of ¥6,377,175,641.39 in Q2 2021, with a net profit attributable to shareholders of ¥350,179,550.23[31]. - Sales of high-value-added products such as specialty starches, specialty starch sugars, specialty alcohols, and specialty citric acid saw significant year-on-year growth, reaching historical highs[52]. - The sales volume of specialty products, including "small specialty new" syrup, exceeded 100,000 tons, achieving a year-on-year growth of over 40%[66]. - The company successfully reduced raw material costs by importing over 200,000 tons of cassava, leveraging price differences between domestic corn and imported cassava[65]. - The company’s domestic revenue was ¥21,814,785,206.18, representing 92.95% of total revenue, with a year-on-year growth of 19.62%[72]. Governance and Management - The governance structure has been strengthened, with the addition of two independent directors to the board[151]. - The company’s management team includes several independent directors, enhancing governance and oversight[159]. - The company is committed to maintaining high standards of corporate governance and transparency in its operations[163]. - The total remuneration for directors, supervisors, and senior management in 2021 amounted to 11.55 million yuan (pre-tax), with independent directors receiving a total of 360,000 yuan (pre-tax)[174]. - The company held a total of 10 board meetings during the reporting period, with all directors attending at least one meeting in person[182]. Employee and Training Initiatives - The company has a total of 8,413 employees, with 7,245 in production, 273 in sales, 399 in technology, 220 in finance, and 276 in administration[189]. - The company conducted over 1,200 training sessions in 2021, with a total of 17,000 participants, aimed at enhancing talent quality and organizational vitality[194]. - The company has established a talent training system that covers management, professional, and technical personnel[194].

Financial Performance - Revenue for Q1 2022 was CNY 5,380,135,205.78, a decrease of 4.26% compared to CNY 5,619,402,840.05 in the same period last year[3] - Net profit attributable to shareholders was CNY 348,969,121.63, down 1.90% from CNY 355,745,352.30 year-on-year[3] - Total operating revenue for the current period is ¥5,380,135,205.78, a decrease of 4.26% from ¥5,619,402,840.05 in the previous period[26] - Net profit for the current period is ¥351,613,777.03, down 4.99% from ¥368,490,603.57 in the previous period[29] - The company reported a total comprehensive income of ¥339,459,236.62, down from ¥364,599,052.96 in the previous period[32] Cash Flow - Net cash flow from operating activities was negative CNY 63,556,964.26, a decline of 112.24% compared to CNY 519,066,471.27 in the previous year[3] - Cash flow from operating activities totaled ¥6,847,784,435.93, down 10.09% from ¥7,616,032,616.85 in the previous period[33] - The net cash flow from operating activities was -$63.56 million, a significant decrease compared to $519.07 million in the previous period[36] - Total cash outflow from operating activities amounted to $6.91 billion, slightly down from $7.10 billion year-over-year[36] - The net cash flow from investment activities was -$232.88 million, improving from -$287.26 million year-over-year[36] - Cash inflow from financing activities totaled $1.93 billion, down from $3.44 billion in the previous period[36] - The net cash flow from financing activities was $515.49 million, compared to $601.57 million in the prior year[36] - The ending cash and cash equivalents balance was $1.33 billion, down from $1.48 billion year-over-year[36] Assets and Liabilities - Total assets increased by 4.62% to CNY 18,897,067,009.31 from CNY 18,062,119,861.99 at the end of the previous year[3] - Current assets amounted to RMB 8,490,911,961.52, up from RMB 7,634,382,643.86 at the beginning of the year, reflecting a growth of approximately 11.25%[19] - Total liabilities reached RMB 6,795,200,779.60, compared to RMB 6,303,423,281.92 at the beginning of the year, marking an increase of approximately 7.8%[22] - The company’s non-current assets totaled RMB 10,406,155,047.79, slightly down from RMB 10,427,737,218.13, indicating a decrease of approximately 0.2%[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 132,711[12] - The largest shareholder, COFCO Bio-chemical Investment Co., Ltd., holds 47.34% of the shares, totaling 883,233,262 shares[12] - Shareholders' equity attributable to the parent company rose by 2.99% to CNY 11,737,714,385.35 from CNY 11,397,350,949.32[3] - The company's equity attributable to shareholders increased to RMB 11,737,714,385.35 from RMB 11,397,350,949.32, reflecting a growth of about 2.98%[25] Research and Development - Research and development expenses increased by 51.01% to CNY 39,032,316.59 from CNY 25,847,519.63 year-on-year[7] - Research and development expenses increased to ¥39,032,316.59, up 51.06% from ¥25,847,519.63 in the previous period[26] Other Income and Expenses - Other income surged by 3518.25% to CNY 246,188,806.58, primarily due to increased government subsidies from asset disposals[7] - Other income increased significantly to ¥246,188,806.58 from ¥6,804,076.22, marking a substantial rise[26] - Investment income decreased by 127.89% to negative CNY 9,237,987.17, mainly due to losses from derivatives and investments in associates[7] - Investment losses amounted to ¥9,237,987.17, compared to a gain of ¥33,126,894.63 in the previous period[26]

Financial Performance - The company's revenue for Q3 2021 reached ¥6,059,928,874.39, representing a year-over-year increase of 29.51%[3] - Net profit attributable to shareholders was ¥234,913,119.48, up 39.55% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥218,073,547.50, reflecting a 35.83% increase year-over-year[3] - Basic earnings per share for the quarter were ¥0.1271, an increase of 39.52% from the previous year[3] - The total operating revenue for the third quarter of 2021 was CNY 18,056,507,355.83, an increase of 29.4% compared to CNY 13,985,108,276.99 in the same period of 2020[24] - The total operating profit was 1,264,443,338.78, compared to 707,149,780.57 in the previous period, indicating an increase of about 78.7%[29] - The total profit amounted to 1,270,074,673.31, up from 702,970,785.13 in the previous period, reflecting an increase of approximately 80.5%[29] - The total comprehensive income amounted to 915,344,981.71, up from 528,717,611.50 in the previous period, indicating a growth of about 73.2%[30] Cash Flow - The operating cash flow net amount for the year-to-date period was ¥5,246,962,076.13, showing a significant increase of 29,658.88%[9] - The cash inflow from operating activities totaled 21,114,919,448.02, compared to 17,252,158,733.04 in the previous period, marking an increase of about 22.5%[34] - The cash outflow from operating activities was 15,867,957,371.89, down from 17,269,909,616.70 in the previous period, showing a decrease of approximately 8.1%[34] - The net cash flow from operating activities was 5,246,962,076.13, a significant improvement from -17,750,883.66 in the previous period[34] - The net cash flow from investing activities was -$659.18 million, an increase from -$539.18 million year-over-year[37] - Total cash inflow from financing activities decreased to $5.32 billion from $6.25 billion year-over-year[37] - Cash outflow for debt repayment increased significantly to $8.99 billion from $4.62 billion year-over-year[37] - The net cash flow from financing activities was -$3.95 billion, compared to a positive $491.03 million in the previous year[37] - The ending cash and cash equivalents balance was $1.28 billion, up from $611.63 million year-over-year[37] Assets and Liabilities - Total assets at the end of the reporting period were ¥18,372,990,078.84, a decrease of 10.31% from the end of the previous year[3] - As of September 30, 2021, the company's total assets amounted to CNY 18,372,990,078.84, a decrease from CNY 20,484,494,619.23 at the end of 2020[22] - The total liabilities as of September 30, 2021, were CNY 6,755,820,673.67, down from CNY 9,682,699,797.15 at the end of 2020[22] - The company's equity attributable to shareholders increased by 7.77% to ¥11,201,562,970.13 compared to the end of the previous year[5] - The company's equity attributable to shareholders increased to CNY 11,201,562,970.13 from CNY 10,393,677,843.62, reflecting a growth of 7.8%[22] - The company reported a significant reduction in short-term borrowings, which decreased to CNY 2,610,480,619.62 from CNY 6,594,526,775.21, a decline of 60.4%[22] Expenses - The total operating costs for the third quarter of 2021 were CNY 16,803,012,678.88, up from CNY 13,171,560,224.38 in the previous year, reflecting a growth of 27.5%[24] - Financial expenses rose by 77.50% due to an increase in loan scale during the reporting period[9] - Research and development expenses were 131,058,912.06, compared to 109,969,955.81 in the previous period, representing an increase of approximately 19.3%[29] - The income tax expense was 321,481,578.82, compared to 146,535,315.45 in the previous period, which is an increase of about 119.0%[29] Strategic Developments - The company did not report any new strategies related to product development or market expansion in this quarter[8] - The company has not disclosed any new product developments or market expansion strategies during this reporting period[18] - The company did not undergo an audit for the third quarter report[38]

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 11,996,578,481.44, representing a 28.91% increase compared to CNY 9,306,025,166.76 in the same period last year [28]. - The net profit attributable to shareholders of the listed company reached CNY 705,924,902.53, a significant increase of 93.19% from CNY 365,409,417.14 in the previous year [28]. - The net profit after deducting non-recurring gains and losses was CNY 661,059,514.61, up 84.48% from CNY 358,343,889.96 year-on-year [28]. - The net cash flow from operating activities was CNY 2,069,062,343.36, a remarkable increase of 821.01% compared to a negative cash flow of CNY -286,966,079.81 in the same period last year [28]. - Basic earnings per share rose to CNY 0.3814, reflecting a 93.02% increase from CNY 0.1976 in the previous year [28]. - The total assets at the end of the reporting period were CNY 20,749,659,060.70, showing a 1.29% increase from CNY 20,484,494,619.23 at the end of the previous year [28]. - The net assets attributable to shareholders of the listed company increased by 5.65% to CNY 10,980,942,835.94 from CNY 10,393,677,843.62 at the end of the previous year [28]. Revenue Breakdown - The fuel ethanol segment generated revenue of ¥6,237,543,200.34, accounting for 51.99% of total revenue, with a year-on-year growth of 31.03% [46]. - Domestic revenue accounted for 94.49% of total revenue, amounting to CNY 11.34 billion, with a year-on-year growth of 37.49% [49]. - The company's total revenue for the reporting period reached approximately CNY 11.81 billion, representing a year-on-year increase of 29.79% [49]. - The average selling price of edible oil was 1.02 million yuan per ton, contributing 42,812.61 million yuan in revenue, representing 81.00% of total sales [131]. - Sugar sales generated 39,707.64 million yuan, with an average price of 0.29 million yuan per ton, accounting for 51.00% of total sales [131]. - The total revenue from feed sales was 10,574.9 million yuan, with an average price of 0.19 million yuan per ton, making up 11.00% of total sales [131]. Cost Management - The gross profit margin improved, with operating costs amounting to ¥10,407,511,390.49, an increase of 26.78% year-on-year, indicating effective cost management despite high raw material prices [46]. - The company has a strategy to leverage both domestic and international raw material markets to control costs effectively [73]. Environmental Compliance - The company maintained a 100% compliance rate in environmental inspections and product quality checks, ensuring stable operations [45]. - The company has established wastewater treatment facilities across all 12 subsidiaries, employing a treatment process that includes pre-treatment, anaerobic, aerobic, and advanced treatment, all of which are operating normally [91]. - The company is actively engaged in environmental self-monitoring, adhering to the requirements of pollution discharge permits and environmental impact assessment documents [95]. - The company reported a COD level of 71.15 and ammonia nitrogen level of 3.17 in its wastewater from the Hengshui facility, with a total of 300 for COD and 30 for ammonia nitrogen as the compliance standard [91]. Innovation and Development - The company received one China Patent Gold Award and 18 authorized patents during the reporting period, enhancing its innovation capabilities [41]. - COFCO Biotech has developed six new domestic technologies for cellulose fuel ethanol production, holding 55 authorized patents, positioning itself as a leader in this field [101]. - The company is committed to energy structure transformation and CO2 recycling to lower greenhouse gas emissions from its factories [100]. Shareholder and Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares [7]. - The total share capital of the company decreased from 1,865,763,788 shares to 1,865,717,988 shares [81]. - The company has not disposed of any significant assets or equity during the reporting period [67][68]. - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period [116]. Risk Management - The company has implemented risk control measures for derivative investments to mitigate market, liquidity, credit, operational, and legal risks [65]. - The company's independent directors believe that the derivative business enhances competitive advantages and is manageable in terms of risk [66]. Community Engagement - COFCO Biotech allocated RMB 6 million to support rural revitalization efforts in Tibet, benefiting 72 households and 281 individuals, with project progress leading among simultaneous initiatives [100]. - The company is actively involved in poverty alleviation and rural revitalization, with initiatives including agricultural technology training achieving a 90% household participation rate [99].

Financial Performance - The company's operating revenue for 2020 was ¥19,909,350,658.56, representing a 2.25% increase compared to ¥19,471,955,122.45 in 2019[23] - The net profit attributable to shareholders for 2020 was ¥593,116,803.94, a slight increase of 0.05% from ¥592,821,396.27 in 2019[23] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥521,231,909.82, an increase of 28.65% compared to ¥405,170,523.35 from the previous year[26] - The net cash flow from operating activities was -¥2,910,855,638.13, a decrease of 179.76% compared to ¥3,649,709,320.82 from the previous year[26] - Total assets increased by 19.40% to ¥20,484,494,619.23 from ¥17,156,862,702.52 at the end of the previous year[26] - The weighted average return on equity was 5.86%, down from 6.21% in the previous year[26] - The company achieved a total operating revenue of ¥19,909,350,658.56 in 2020, representing a year-on-year increase of 2.25%[60] - The revenue from fuel ethanol and its by-products was ¥9,617,670,959.00, accounting for 48.31% of total revenue, with a growth of 3.39% compared to the previous year[60] - The total revenue for 2020 was 20,600,000,000 CNY, with a year-on-year increase of 4.20%[71] Shareholder Information - The company plans to distribute a cash dividend of ¥0.65 per 10 shares to all shareholders, based on a total of 1,865,717,988 shares[7] - The company’s basic earnings per share remained stable at ¥0.3209, with diluted earnings per share slightly decreasing to ¥0.3202[26] - In 2020, the company distributed cash dividends of 0.65 yuan per 10 shares, totaling 121,271,669.22 yuan, which represents 20.45% of the net profit attributable to shareholders[127][129] Business Operations - The company’s main business has shifted to include the production and sales of fuel ethanol, edible alcohol, starch, starch sugar, citric acid, and monosodium glutamate since 2018[21] - The company reported a significant increase in production capacity and market expansion efforts in the biofuel sector[21] - The company achieved total sales of nearly 600,000 tons of specialty products, including waxy corn starch and flavored syrup, enhancing its profitability structure[39] - The company maintained profitability in fuel ethanol products despite a decline in sales prices due to falling international oil prices[38] - The company’s main products, including alcohol and starch, saw price increases, enhancing its profitability despite a challenging market environment[55] - The company’s ethanol business optimized production facilities, achieving a market share of 40% in fuel ethanol, disinfection alcohol, and edible alcohol, ranking first in the industry[56] - The company trained over 16,000 employees through its "COFCO Technology University" initiative, improving labor efficiency by over 10%[56] Research and Development - The company continues to focus on research and development of new products and technologies to enhance its market position[21] - The company increased its research and development investment, establishing four R&D bases and two national research centers, which enhanced its ability to launch high-value-added new products[41] - The company reported a significant increase in research and development expenses, totaling 113,672,793.15 CNY, a 30.43% increase compared to the previous year[78] - The company integrated R&D resources, currently holding 8 national key R&D projects, enhancing its innovation-driven development strategy[56] - The company plans to increase R&D investment in specialized starch, waxy corn modified starch, specialized syrup, high-end maltodextrin, functional sugars, and specialty alcohols to enhance market share[120] Environmental and Social Responsibility - The company supplied approximately 400,000 tons of medical and disinfectant alcohol to 25 provinces and cities in China during the pandemic, showcasing its commitment to social responsibility[42] - The company plans to respond to national plastic pollution control policies by developing a full industrial chain for green biodegradable materials[38] - The company maintained a 100% compliance rate in 113 supervisory inspections, demonstrating its commitment to environmental protection and sustainable development[44] - The company is committed to high-quality development and sustainable innovation in line with the new development pattern[117] - The company has a commitment to sustainable development, emphasizing renewable bioenergy and biodegradable materials in its product offerings[199] - The company allocated CNY 6 million for poverty alleviation efforts, focusing on industry-based support in targeted areas[200] Inventory and Cash Flow - The company's inventory and prepaid auction grain payments increased, contributing to a significant difference between net cash flow from operating activities and net profit[86] - Inventory increased significantly from ¥2,802,537,253.55 (16.30% of total assets) to ¥4,991,461,587.39 (24.37% of total assets), reflecting an increase of 8.07%[88] - The net cash flow from financing activities increased by 221.51% to ¥3,754,583,318.86, primarily due to an increase in share capital and borrowings[86] - The company reported an asset impairment loss of ¥276,552,833.45, which represented -34.49% of total profit, mainly due to indications of inventory impairment[87] Corporate Governance and Compliance - The company has not faced any penalties or rectification issues during the reporting period[155] - The integrity status of the company and its controlling shareholders is good, with no significant debts or court judgments outstanding[156] - The company has committed to ensuring that any unavoidable related transactions are conducted fairly and legally, protecting the interests of the listed company and its shareholders[139] - 中粮集团 committed to avoiding competition with the listed company and ensuring fair treatment in related transactions[143] - The company has established a long-term commitment to avoid related transactions unless absolutely necessary[139] Market Position and Strategy - The company maintains a leading position in the domestic fuel ethanol industry, with a market share of approximately 40%[115] - The company plans to focus on high-demand, high-margin specialty products, including modified starches and functional alcohols, to meet market needs[117] - The biodegradable materials market is experiencing rapid growth, with demand for polylactic acid (PLA) products increasing significantly[116] - The company aims to enhance its production capabilities for starch, sugar, and lactic acid to support its PLA business[117] - The company will implement a procurement strategy to reduce costs and expand the range of quality raw materials in 2021[118] Related Party Transactions - The company reported related party transactions amounting to 57.06 million RMB for packaging materials, accounting for 21.36% of similar transactions[165] - The company also reported related party service fees totaling 1.23 million RMB, which represents 34.85% of similar service fees[165] - The total actual related party transactions for the listed company in 2020 did not exceed the annual forecast total[173] - The company has not reported any major related party transactions during the reporting period[179]

中粮生物科技股份有限公司 2021 年第一季度报告全文 证券代码：000930 证券简称：中粮科技 公告编号：2021-029 中粮生物科技股份有限公司 2021 年第一季度报告 2021 年 04 月 1 中粮生物科技股份有限公司 2021 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人佟毅、主管会计工作负责人胡昌平及会计机构负责人(会计主管 人员)李观书声明：保证季度报告中财务报表的真实、准确、完整。 2 中粮生物科技股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |-----------------------------------------------------|-------------------|-------------------|--------- ...